Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain
Jia Nong(Translational Therapeutics (United States)), Oscar A. Marcos‐Contreras(Translational Therapeutics (United States)), Colin F. Greineder(Translational Therapeutics (United States)), Scott E. Kasner, Marco E. Zamora(Translational Therapeutics (United States)), Alvin J. Mukalel(University of Pennsylvania), Viviana Zuluaga‐Ramirez(Temple University), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Raisa Y. Kiseleva(Translational Therapeutics (United States)), Serena Omo‐Lamai(Translational Therapeutics (United States)), Yuri Persidsky(Institute for Neurodegenerative Disorders), Carlos H. Villa(Center for Biologics Evaluation and Research), Jacob W. Myerson(Translational Therapeutics (United States)), Drew Weissman(California University of Pennsylvania), Michael J. Mitchell(California Institute for Regenerative Medicine), Patrick M. Glassman(Translational Therapeutics (United States)), Kartik Bhamidipati(Translational Therapeutics (United States)), Alba Rodríguez-García(Cancer Research Center), Zhicheng Wang(Translational Therapeutics (United States)), Silvia Muro(National Center for Advancing Translational Sciences), Xijing Gong(University of Pennsylvania), Landis R. Walsh(Translational Therapeutics (United States))
Cited by 28
Related Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
|Stroke|2010|1.5k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940